Exondys 51 Market Report 2026
Download Free Sample Buy Now
Exondys 51 Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Exondys 51 Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Exondys 51 Market Overview

• The Exondys 51 market growth in the historic period has been driven by lack of curative dmd therapies, historical reliance on supportive care

• Market expansion is supported by advancements in molecular genetics, expansion of personalized neuromuscular care

• Growth Driver: Rising Burden Of Genetic Disorders Driving Growth In The Market

• Market Trend: Enhanced Safety Monitoring and Label Refinement in the Exondys 51/ELEVIDYS Market

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Exondys 51 Market?

Exondys 51 (eteplirsen) is a medication used to treat duchenne muscular dystrophy (DMD) by promoting exon-skipping of the dystrophin gene, allowing the production of a functional but shortened dystrophin protein. Exondys 51 works by skipping over exon 51 of the dystrophin gene, allowing the production of a shortened but functional version of the dystrophin protein.

The main types of indications in exondys 51 are relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPMS), and other multiple sclerosis forms. Relapsing-remitting multiple sclerosis (RRMS) refers to the most common form of multiple sclerosis, characterized by clearly defined relapses or attacks of neurological symptoms. It is distributed through hospital pharmacies, specialty pharmacies, and online pharmacies, and applications include subcutaneous injection, long-term disease management, and prophylactic use.

Exondys 51 Market Global Report 2026 Market Report bar graph

What Is The Exondys 51 Market Size and Share 2026?

The growth in the historic period can be attributed to lack of curative dmd therapies, historical reliance on supportive care, early antisense research, rare disease drug incentives, initial regulatory approvals.

What Is The Exondys 51 Market Growth Forecast?

The growth in the forecast period can be attributed to advancements in molecular genetics, expansion of personalized neuromuscular care, rising newborn screening initiatives, increased research funding for dmd, growing specialty neurology centers. Major trends in the forecast period include growth of exon skipping therapies, expansion of targeted dmd treatments, rising adoption of genetic based medicines, focus on slowing disease progression, increasing long term therapy management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Exondys 51 Market Segmentation

1) By Clinical Indication: Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Other Multiple Sclerosis Forms

2) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

3) By Application: Subcutaneous Injection, Long-Term Disease Management, Prophylactic Use

What Are The Drivers Of The Exondys 51 Market?

The rising burden of genetic disorders is expected to propel the growth of the exondys 51 market going forward. Genetic disorders refer to conditions that are caused by abnormalities or mutations in an individual's DNA or genetic material. The rising burden of genetic disorders can be attributed to several factors, including advancements in medical technology, changes in demographics, and improvements in diagnosis and awareness. Exondys 51 (eteplirsen) treats genetic disorders by enabling exon 51 skipping in the dystrophin gene, allowing the production of a functional, though shortened, dystrophin protein to slow muscle degeneration. For instance, in July 2024, according to the National Health Service, a UK-based government department, approximately 70,000 individuals are affected by muscular dystrophy (MD) or a related condition in the UK, with Duchenne MD being the most prevalent form. Each year, around 100 boys are diagnosed with Duchenne MD, and approximately 2,500 people in the UK are living with the condition at any given time. Therefore, the rising burden of genetic disorders is driving the growth of the exondys 51 industry.

Rising investments in healthcare are expected to boost the growth of the exondys 51 market going forward. Healthcare investments refer to the allocation of financial resources toward entities, technologies, services, or innovations in the healthcare sector. Healthcare investments are rising due to increasing demand for chronic disease management from aging populations and funding for advanced technologies such as telemedicine to improve healthcare delivery. Healthcare investments drive exondys 51 by funding research, clinical trials, and technologies such as exon-skipping, which enable the treatment of duchenne muscular dystrophy and improve patient access through programs and infrastructure support. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure increased by 5.6% in nominal terms from 2022 to 2023, marking a significant rise compared to the 0.9% growth seen in 2022. Therefore, rising investments in healthcare are driving the growth of the exondys 51 industry.

Key Players In The Global Exondys 51 Market

Major companies operating in the exondys 51 market are Sarepta Therapeutics

Global Exondys 51 Market Trends and Insights

Major companies operating in the exondys 51 market are focusing on enhancing safety and refining patient selection, such as updating prescribing information for ELEVIDYS to mitigate liver-related risks and ensure appropriate patient eligibility. ELEVIDYS refers to Sarepta Therapeutics’ AAV-based micro-dystrophin gene therapy (delandistrogene moxeparvovec) designed to restore dystrophin expression in patients with Duchenne muscular dystrophy (DMD). For instance, in November 2025, the U.S. FDA, a US-based federal agency, approved an updated label for ELEVIDYS, adding a boxed warning for acute serious liver injury and acute liver failure and limiting its use to ambulatory patients aged four years and older. The update introduces mandatory weekly liver-function testing for the first three months post-infusion, requires corticosteroid pre- and post-dosing, and advises patients to remain near a qualified healthcare facility for at least two months, all aimed at improving safety monitoring and patient outcomes.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the exondys 51 market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Exondys 51 Market?

The exondys 51 market consists of sales of products including golodirsen (Vyondys 53), viltolarsen (Viltepso), and casimersen (Amondys 45). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Exondys 51 Market Report 2026?

The exondys 51 market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the exondys 51 industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Exondys 51 Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Clinical Indication, Distribution Channel, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Sarepta Therapeutics
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Exondys 51 Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Exondys 51 Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Exondys 51 Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Exondys 51 Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Digitalization, Cloud, Big Data And Cybersecurity

4.1.3 Industry 4.0 And Intelligent Manufacturing

4.1.4 Sustainability, Climate Tech And Circular Economy

4.1.5 Internet Of Things, Smart Infrastructure And Connected Ecosystems

4.2. Major Trends

4.2.1 Growth Of Exon Skipping Therapies

4.2.2 Expansion Of Targeted Dmd Treatments

4.2.3 Rising Adoption Of Genetic Based Medicines

4.2.4 Focus On Slowing Disease Progression

4.2.5 Increasing Long Term Therapy Management

5. Exondys 51 Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Neurology Clinics

5.3 Pediatric Care Centers

5.4 Ambulatory Care Centers

5.5 Home Care Providers

6. Exondys 51 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Exondys 51 Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Exondys 51 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Exondys 51 Market Size, Comparisons And Growth Rate Analysis

7.3. Global Exondys 51 Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Exondys 51 Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Exondys 51 Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Exondys 51 Market Segmentation

9.1. Global Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Other Multiple Sclerosis Forms

9.2. Global Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

9.3. Global Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Subcutaneous Injection, Long-Term Disease Management, Prophylactic Use

10. Exondys 51 Market Regional And Country Analysis

10.1. Global Exondys 51 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Exondys 51 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Exondys 51 Market

11.1. Asia-Pacific Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Exondys 51 Market

12.1. China Exondys 51 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Exondys 51 Market

13.1. India Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Exondys 51 Market

14.1. Japan Exondys 51 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Exondys 51 Market

15.1. Australia Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Exondys 51 Market

16.1. South Korea Exondys 51 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Exondys 51 Market

17.1. Western Europe Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Exondys 51 Market

18.1. UK Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Exondys 51 Market

19.1. Germany Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Exondys 51 Market

20.1. France Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Exondys 51 Market

21.1. Eastern Europe Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Exondys 51 Market

22.1. North America Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Exondys 51 Market

23.1. USA Exondys 51 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Exondys 51 Market

24.1. Canada Exondys 51 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Exondys 51 Market

25.1. South America Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Exondys 51 Market

26.1. Middle East Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Exondys 51 Market

27.1. Africa Exondys 51 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Exondys 51 Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Exondys 51 Market Regulatory and Investment Landscape

29. Exondys 51 Market Competitive Landscape And Company Profiles

29.1. Exondys 51 Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Exondys 51 Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Exondys 51 Market Company Profiles

29.3.1. Sarepta Therapeutics Overview, Products and Services, Strategy and Financial Analysis

30. Global Exondys 51 Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Exondys 51 Market

32. Exondys 51 Market High Potential Countries, Segments and Strategies

32.1 Exondys 51 Market In 2030 - Countries Offering Most New Opportunities

32.2 Exondys 51 Market In 2030 - Segments Offering Most New Opportunities

32.3 Exondys 51 Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Exondys 51 Market, Overview Of Key Products - Product Examples
  • Table 2: Global Exondys 51 Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Exondys 51 Market, Supply Chain Analysis
  • Table 4: Global Exondys 51 Market, Major Raw Material Providers
  • Table 5: Global Exondys 51 Market, Major Resource Providers
  • Table 6: Global Exondys 51 Market, Major Manufacturers (Suppliers)
  • Table 7: Global Exondys 51 Market, Major Distributors And Channel Partners
  • Table 8: Global Exondys 51 Market, Key Technologies & Future Trends
  • Table 9: Global Exondys 51 Market, Major Trends
  • Table 10: Global Exondys 51 Market, Major End Users
  • Table 11: Global Exondys 51 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Exondys 51 Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Exondys 51 Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Exondys 51 Market - TAM, US$ Billion, 2025
  • Table 15: Global Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Exondys 51 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Exondys 51 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Exondys 51 Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Exondys 51 Market - Company Scoring Matrix
  • Table 73: Sarepta Therapeutics Financial Performance
  • Table 74: Global Exondys 51 Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Exondys 51 Market, Competitive Dashboard
  • Table 76: Global Exondys 51 Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 78: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 79: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Exondys 51 Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Exondys 51 Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Exondys 51 Market, Supply Chain Analysis
  • Figure 4: Global Exondys 51 Market, Major Raw Material Providers
  • Figure 5: Global Exondys 51 Market, Major Resource Providers
  • Figure 6: Global Exondys 51 Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Exondys 51 Market, Major Distributors And Channel Partners
  • Figure 8: Global Exondys 51 Market, Key Technologies & Future Trends
  • Figure 9: Global Exondys 51 Market, Major Trends
  • Figure 10: Global Exondys 51 Market, Major End Users
  • Figure 11: Global Exondys 51 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Exondys 51 Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Exondys 51 Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Exondys 51 Market - TAM, US$ Billion, 2025
  • Figure 15: Global Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Exondys 51 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Exondys 51 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Exondys 51 Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Exondys 51 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Exondys 51 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Exondys 51 Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Exondys 51 Market - Company Scoring Matrix
  • Figure 73: Sarepta Therapeutics Financial Performance
  • Figure 74: Global Exondys 51 Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Exondys 51 Market, Competitive Dashboard
  • Figure 76: Global Exondys 51 Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 78: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 79: Global, Exondys 51 Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

ESG Finance Market Report 2026 - Global Outlook – By Investment Type (Equity, Fixed Income, Mixed Allocation, Other Investment Types), By Investor Type (Institutional Investors, Retail Investors), By Transaction Type (Gr...

Smart Finance Hardware Market Report 2026 - Global Outlook – By Product (Modules, Sensors, Other Products), By Connectivity Technology (Near Field Communication (NFC), EMV Chip Technology, Magnetic Stripe Technology, Blu...

Business-to-Business Electronic Market Report 2026 - Global Outlook – By Deployment Type (Supplier-Oriented, Buyer-Oriented, Intermediary-Oriented), By Application (Home And Kitchen, Consumer Electronics, Healthcare, Clo...

Exchange Traded Fund Market Report 2026 - Global Outlook – By Investment Style (Passive Exchange Traded Funds (ETFs), Active Exchange Traded Funds (ETFs), Smart Beta Exchange Traded Funds (ETFs)), By Asset Class (Equity ...

Exosome Technologies Market Report 2026 - Global Outlook – By Exosome Type (Loaded Cargos, Non-Cargo), By Cell Source (HEK293 Cells, Mesenchymal Stem Cells (MSCs), Platelets, Erythrocytes, Natural Killer Cells, Other Cel...

Cryptocurrency Exchange Platform Market Report 2026 - Global Outlook – By Type (Centralized Exchange, Decentralized Exchange), By Trading Type (Spot Trading, Derivatives Trading), By Cryptocurrency Type (Bitcoin, Ethereu...

Alternative Finance Market Report 2026 - Global Outlook – By Type (Peer-To-Peer Lending, Crowdfunding, Invoice Trading, Other Types), By Business Model (Non-Bank Lending, Alternate Marketplace Lending), By End User (Ente...

Frequently Asked Questions

The Exondys 51 market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Exondys 51 market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Exondys 51 market Include, Sarepta Therapeutics .

Major trend in this market includes: Enhanced Safety Monitoring and Label Refinement in the Exondys 51/ELEVIDYS Market . For further insights on this market. request a sample here

North America was the largest region in the exondys 51 market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the exondys 51 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us